Products
Platform
Research
Market
Learn
Partner
Support
IPO

P

Parmax Pharma Share Price

38.39
+5.06 (15.18%)
PARMAX • 19 Jan, 2026 | 03:29 PM

1Y Annualised Return

-11.14%

3Y Annualised Return

-2.27%

5Y Annualised Return

5.55%

The current prices are delayed, login or Open Demat Account for live prices.

Parmax Pharma Stock Performance

1W Return-0.80
1Y Return2.40
Today's Low38.39
Prev. Close33.33
Mkt Cap (Cr.)14.36
1M Return23.84
3Y Return3.20
52-Week High55.02
Open39.69
PE Ratio0.00
6M Return-6.05
Today's High39.69
52-Week Low28
Face Value10

Parmax Pharma Company background

Founded in: 1994
Incorporated in Nov.94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara. The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmaxs pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc. The Company then discontinued their business activities for few years due to various reasons. Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994 the Company had set up a plant to manufacture and market bulk drugs like amoxycillin trihydrate, ampicillin trihydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA. Antibiotic project was fully implemented from 31st May97.

Parmax Pharma Share Price Today


As of 19 Jan 2026, Parmax Pharma share price is ₹38.4. The stock opened at ₹39.7 and had closed at ₹33.3 the previous day. During today’s trading session, Parmax Pharma share price moved between ₹38.39 and ₹39.69, with an average price for the day of ₹39.04. Over the last 52 weeks, the stock has recorded a low of ₹28.00 and a high of ₹55.02. In terms of performance, Parmax Pharma share price has declined by 6% over the past six months and has declined by 11.14% over the last year.
Read More
Parmax Pharma SIP Return Calculator
5,000
Over the past
Total Investment of ₹0
Monthly SIP of 5,000 would have become 0 in 5 years with a gain of 0 (+0.00%)
View details of Market Depth

Parmax Pharma Fundamental

Market Cap (in crs)

14.36

Face Value

10

Turnover (in lacs)

0.01

Key Metrics

Qtr Change %
30.23% Fall from 52W High
11.5
Dividend yield 1yr %
0

Parmax Pharma Shareholding Pattern

Promoter
30.8%
Public
69.2%

Parmax Pharma Technical Analysis

Moving Averages Analysis
38.39
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
Day EMA5
36.40
Day EMA10
35.70
Day EMA12
35.50
Day EMA20
34.80
Day EMA26
34.40
Day EMA50
33.90
Day EMA100
34.40
Day EMA200
36.10
Delivery & Volume
Loading chart...

Day

79.20%

Week

78.90%

Month

90.10%

Delivery & Volume

38.82
Pivot
Resistance
First Resistance
39.26
Second Resistance
40.12
Third Resistance
40.56
Support
First Support
37.96
Second support
37.52
Third Support
36.66
Relative Strength Index
58.10
Money Flow Index
86.30
MACD
1.06
MACD Signal
0.76
Average True Range
3.95
Average Directional Index
13.06
Rate of Change (21)
12.91
Rate of Change (125)
-8.55
Compare

Parmax Pharma Latest News

12 JAN 2026 | Monday
30 DEC 2025 | Tuesday
17 NOV 2025 | Monday

Please be aware that Parmax Pharma stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account